These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2433537)

  • 1. Overview of cardiac inotropic mechanisms.
    Siegl PK
    J Cardiovasc Pharmacol; 1986; 8 Suppl 9():S1-10. PubMed ID: 2433537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of calcium ions and the participation of the mitochondria in realizing the positive inotropic action of cardiac glycosides (a review of the literature)].
    Denisov IuP
    Farmakol Toksikol; 1980; 43(6):740-5. PubMed ID: 6256209
    [No Abstract]   [Full Text] [Related]  

  • 3. Classification of positive inotropic actions based on electrophysiologic characteristics: where should calcium sensitizers be placed?
    Varro A; Papp JG
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S32-44. PubMed ID: 8907129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of action of positive inotropic substances].
    Godfraind T
    Ann Cardiol Angeiol (Paris); 1984; 33(4):197-201. PubMed ID: 6087713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac actions of vanadium.
    Akera T; Temma K; Takeda K
    Fed Proc; 1983 Oct; 42(13):2984-8. PubMed ID: 6311633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The basic mechanism of inotropic action of digitalis glycosides.
    Smith TW
    J Pharmacol; 1984; 15 Suppl 1():35-51. PubMed ID: 6328127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physiology and cell biology of the heart].
    Tada M
    Tanpakushitsu Kakusan Koso; 1990 Jul; 35(10):1607-16. PubMed ID: 2173024
    [No Abstract]   [Full Text] [Related]  

  • 8. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
    McCall D
    Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profile of the new inotropic agent AT-11.
    Lee AS; Wu TS; Su MJ
    Eur J Pharmacol; 2008 Feb; 580(1-2):224-30. PubMed ID: 18031738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Characteristics of the biochemical mechanisms of electromechanical coupling in the myocardium].
    Boldyrev AA
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1982; (4):5-17. PubMed ID: 6282345
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of chronic heart failure with positive inotropic drugs].
    Erdmann E
    Internist (Berl); 1986 May; 27(5):298-305. PubMed ID: 3015821
    [No Abstract]   [Full Text] [Related]  

  • 12. New positive inotropic agents acting by phosphodiesterase inhibition or alpha 1-adrenergic stimulation.
    von der Leyen H; Schmitz W; Scholz H; Scholz J
    Pharmacol Res; 1989; 21(4):329-37. PubMed ID: 2570416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium entry via L-type calcium channels acts as a negative regulator of adenylyl cyclase activity and cyclic AMP levels in cardiac myocytes.
    Yu HJ; Ma H; Green RD
    Mol Pharmacol; 1993 Oct; 44(4):689-93. PubMed ID: 7694067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100.
    Hayes JS; Wyss VL; Wilson HC; Robertson DW; Kauffman RF
    J Pharmacol Exp Ther; 1986 Nov; 239(2):375-81. PubMed ID: 3021955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of cAMP: mechanism for positive inotropic action.
    Evans DB
    J Cardiovasc Pharmacol; 1986; 8 Suppl 9():S22-9. PubMed ID: 2433539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Present and future trends in research and clinical applications of inodilators.
    Cargnelli G; Piovan D; Bova S; Padrini R; Ferrari M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S124-32. PubMed ID: 2483438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacological investigation of the contribution of muscarinic receptor-linked potassium channels to the reversal by carbachol of positive inotropic responses of rabbit left atrium to cyclic AMP-generating agents.
    Ray A; MacLeod KM
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1594-601. PubMed ID: 7690405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Na+,K(+)-ATPase by flavonoids and their inotropic effect. Investigation of the structure-activity relationship.
    Umarova FT; Khushbactova ZA; Batirov EH; Mekler VM
    Membr Cell Biol; 1998; 12(1):27-40. PubMed ID: 9829256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of calcium-sensitizing agents.
    Vegh A; Papp JG; Udvary E; Kaszala K
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S20-31. PubMed ID: 8907128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the positive inotropic action of 6,7-dimethoxy-3-cyano-3,4-dihydrocarbostyril.
    Ferrini R; Miragoli G; Calabi ML; Santangelo F; Godfraind T; Bravo G; Casagrande C
    Arzneimittelforschung; 1996 Feb; 46(2):139-45. PubMed ID: 8720302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.